Mixing studies are conducted to assess unexpected, prolonged prothrombin time (PT). The mixing study aims to recognize whether the PT prolongation is ancillary to a factor deficiency versus an inhibitor. The distinction between a factor deficiency and an inhibitor may further direct clinical decisions, comprising additional diagnostic testing or factor replacement therapy.